FMC Announces With Research Partner AgroSpheres That Two Proprietary RNA-Based Biomolecule Candidates From Agrospheres' Pipeline Are Now Entering Global Field Trial Development
Trials mark the transition from discovery into real-world testing across three continents. The candidates, developed under the companies' collaboration first announced in 2024, represent a new category of
FMC and its partner are testing new plant medicines in real fields worldwide. This moves their science from the lab into the real-world testing stage, which is an important step forward.
Last session drawn · prints held ~15 minutes · licensed exchange data
Source: Benzinga · Read the original report at the publisher. Headline and figures shown for context; data may be delayed.
Disclosure: Educational and informational purposes only. Not financial advice. We educate, not advise. Market data may be delayed up to 15 minutes unless marked real-time. Past performance is not indicative of future results.